NIH-funded research P01 program project

Understanding how diabetes affects tuberculosis and the body’s defense against it

Official title: Dissecting the determinants of Mycobacterium tuberculosis fitness through the lens of diabetes mellitus comorbidity

Funded at Washington University · NIH-11451472 · Data updated 2026-11-12

A patient-focused look at how having diabetes changes the way the immune system fights tuberculosis and how this might influence treatment in people with both conditions.

More Diabetes research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 15, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$450,828
NIH project number1P01AI201081-01
Project IDNIH-11451472 on NIH RePORTER

Who could benefit from this research

Could help

People living with both diabetes and tuberculosis or those at high risk of TB who also have diabetes.

Less likely to help

People without diabetes or TB are unlikely to directly benefit from this project.

What this research studies

This program explores why people with diabetes may be more susceptible to tuberculosis and how diabetes changes immune cell behavior in the lungs. Researchers study how lung macrophages and neutrophils respond to TB infection when diabetes is present, using models that reflect both conditions. The work aims to map how high blood sugar alters immune signals and cell death pathways that influence TB progression. Results could point to new treatment strategies that better protect people who have both diabetes and TB.

Why it matters

Potential benefit: If successful, the work could lead to more effective TB therapies tailored for people with diabetes.

How similar studies have gone: Prior studies have linked diabetes to worse TB outcomes and altered immune responses, with emerging evidence that metabolic changes influence infection control.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Stallings, Christina Leigh — Washington University
  • Study coordinator: Stallings, Christina Leigh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.